NIH Grants: Fund Your Viral Pathogen Research
Summary
Seeking funding for innovative therapeutics, immunotherapeutics, or diagnostics targeting NIAID Category A, B, or C viral pathogens? This R01 grant from the NIH could provide up to $7.3 million to advance your biodefense research.
Eligibility
Full Description
Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) invites research applications for projects that support development of new therapeutics, immunotherapeutics or medical diagnostics for NIAID Category A, B, or C viral pathogens. Mechanism of Support. This FOA will utilize the R01 grant mechanism.
Funds Available and Anticipated Number of Awards. The NIAID intends to commit $7.3 million in total costs in FY2010 to fund five to ten applications in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.